Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. [electronic resource]
Producer: 20130109Description: 1503-10 p. digitalISSN:- 1546-170X
- Animals
- Apoptosis -- drug effects
- Benzimidazoles -- pharmacology
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Doxycycline -- pharmacology
- Female
- Genes, ras
- Humans
- Melanoma -- drug therapy
- Mice
- Mice, Knockout
- Mice, Nude
- Middle Aged
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Proto-Oncogene Mas
- Proto-Oncogene Proteins p21(ras) -- antagonists & inhibitors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.